← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novadigm Therapeutics, Inc.
Torrance, CA
$13,858,292
Total funding
8
Grants
Funding over time
peak $5.6M · FY2006–11$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
DOD$10,787,478 · 3
NIH$3,070,814 · 5
By mechanism
—$10,787,478 · 3
R42$1,989,750 · 1
R41$782,503 · 3
R43$298,561 · 1
Investigators at Novadigm Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF A STAPHYLOCOCCUS AUREUS ? CANDIDA SP. VACCINE$5,594,000
· FY2011 · Department of Defense
DEVELOPMENT OF A STAPHYLOCOCCUS AUREUS-CANDIDA SP. VACCINE$3,502,000
· FY2010 · Department of the Army
DEVELOPMENT OF CANDIDA-STAPHYLOCOCCUS VACCINE$1,691,478
· FY2009 · Department of the Army
Vaccine Strategies for Candidal Infections$1,000,000
R42 · FY2010 · AI
Vaccine Strategies for Candidal Infections$989,750
R42 · FY2009 · AI
Recombinant Listeria monocytogenes expressing ALS3: a vaccine against candidiasis$298,561
R43 · FY2008 · AI
Novel Context-Activated Protide Anti-Infectives$227,738
R41 · FY2008 · AI
Novel Context-Activated Protide Anti-Infectives$222,262
R41 · FY2007 · AI
Creation and validation of a lux-positive Candida strain$203,713
R41 · FY2007 · AI
Vaccine Strategies for Candidal Infections$128,790
R41 · FY2006 · AI